Skip to main content
letter
. 2021 Jul 7;28(5):798–799. doi: 10.5603/CJ.a2021.0078

Figure 1.

Figure 1

Trial sequential analysis on hospital (30-day) mortality in patients with heart failure (HF), comparing treatment with levosimendan versus dobutamine; RE — random effect; RR — risk reduction.